OBSIDIAN THERAPEUTICS Trademark

Trademark Overview

On Tuesday, July 23, 2019, a trademark application was filed for OBSIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN THERAPEUTICS trademark a serial number of 88530962. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Obsidian Therapeutics, Inc.. The OBSIDIAN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and the prevention and treatment of cardiovascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculoskeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, dermatological disorders and gastroenterological disorders
obsidian therapeutics

General Information

Serial Number88530962
Word MarkOBSIDIAN THERAPEUTICS
Filing DateTuesday, July 23, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements

Description of MarkThe mark consists of the wording "OBSIDIAN THERAPEUTICS" to the right of a seven-sided heptagon shape with lines within the heptagon that create three triangular elements surrounding a quadrilateral.
Goods and ServicesPharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and the prevention and treatment of cardiovascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculoskeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, dermatological disorders and gastroenterological disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameObsidian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 13, 2022SOU EXTENSION 5 GRANTED
Thursday, August 11, 2022SOU EXTENSION 5 FILED
Thursday, August 11, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 9, 2022SOU EXTENSION 4 GRANTED
Wednesday, February 9, 2022SOU EXTENSION 4 FILED
Wednesday, February 9, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 19, 2021CORRECTED NOA E-MAILED
Wednesday, August 18, 2021SOU EXTENSION 3 GRANTED
Wednesday, August 11, 2021SOU EXTENSION 3 FILED
Wednesday, August 18, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, August 11, 2021DIVISIONAL REQUEST RECEIVED
Wednesday, August 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 11, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 11, 2021SOU TEAS EXTENSION RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021SOU EXTENSION 2 GRANTED
Thursday, February 11, 2021SOU EXTENSION 2 FILED
Thursday, February 11, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 7, 2020SOU EXTENSION 1 GRANTED
Friday, August 7, 2020SOU EXTENSION 1 FILED
Friday, August 7, 2020SOU TEAS EXTENSION RECEIVED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2019ASSIGNED TO LIE
Wednesday, November 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 29, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 8, 2019NON-FINAL ACTION E-MAILED
Sunday, September 8, 2019NON-FINAL ACTION WRITTEN
Friday, September 6, 2019ASSIGNED TO EXAMINER
Thursday, August 1, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 26, 2019NEW APPLICATION ENTERED

Related Keywords

therapeutics obsidian disorders system therapy immune metabolic genitourinary musculoskeletal nervous gastroenterological dermatological